Results 211 to 220 of about 9,790 (260)

Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases. [PDF]

Future Med Chem
Mustière R, Dassonville-Klimpt A, Sonnet P.   +2 more
europepmc   +1 more source

Abemaciclib-associated acute interstitial nephritis successfully treated with glucocorticoids: a case report and literature review. [PDF]

BMC Nephrol
Kumano M, Maeoka Y, Teragawa Y, Yanagidani H, Yoshida M, Takahashi A, Masaki T.   +6 more
europepmc   +1 more source

Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients. [PDF]

Oncologist
Canzian J, Gentile D, De Sanctis R, Jacobs F, Benvenuti C, Gaudio M, Gerosa R, Saltalamacchia G, Torrisi R, Masci G, Tinterri C, Zambelli A.   +11 more
europepmc   +1 more source

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report. [PDF]

Oncotarget
Wu JL, Iams WT.
europepmc   +1 more source

A comparative analysis of Palbociclib and Ribociclib in metastatic hormone receptor-positive, HER2-negative breast cancer: a prospective mid term follow-Up study from an Indian cohort. [PDF]

BMC Cancer
Sreenath ND, Pandalanghat S, Kapoor A, Govind R, Kaushik MR, Nair R, Bhuva D, Rathore A, Kumar M, Mulajker D.   +9 more
europepmc   +1 more source

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6 Inhibitors: Evidence from a Ribociclib-Dominant Cohort. [PDF]

Medicina (Kaunas)
Erul E, Öksüz NE, Akkus E, Tolunay PK, Köksoy EB, Yasar HA.   +5 more
europepmc   +1 more source

The Groebke-Blackburn-Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019-2023). [PDF]

Beilstein J Org Chem
Martini C, Mardjan MID, Basso A.
europepmc   +1 more source

Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma: a case report. [PDF]

Cancer Chemother Pharmacol
Gezelius E, Planck M, Hazem B, Nagpal S, Wakelee H.   +4 more
europepmc   +1 more source